APGE

Apogee Therapeutics (APGE)

About Apogee Therapeutics (APGE)

Apogee Therapeutics, Inc. is a clinical stage biotechnology company. It offers treatment of atopic dermatitis (AD), ashma, eosinophilic esophagitis (EoE), chronic obstructive pulmonary disease (COPD) and related inflammatory and immunology (I&I) indications. The company was founded by Andrew Gottesdiener and Nimish P. Shah in 2022 and is headquartered in Waltham, MA.

Details

Daily high

$132.95

Daily low

$132.54

Price at open

$132.58

52 Week High

$133.00

52 Week Low

$34.34

Market cap

10.0B

Dividend yield

0.00%

Volume

4.9M

Avg. volume

4.4M

P/E ratio

-30.63

Apogee Therapeutics News